Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Vision Tests”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 631 records · Page 35Linked to original sources
PubMed1964

VISUAL MASKING.

Explore the source record for details and available documents.

Humans↗
PubMed1992

The Purkinje vascular entoptic test: a halogen light gives better results.

The Purkinje vascular entoptic test is a test of macular function which employs a light directed through the sclera illuminating the fundus. This light casts shadows of retinal blood vessels on to posterior pole photoreceptors. When the light source is moved, a patient with a good macular function should be able to see a negative image of his or her retinal blood vessels. We evaluated the Purkinje test in eyes with clear ocular media. A bright 3.5 watt halogen rechargeable transilluminator was used instead of a pen torch as previously described. Sixty-eight patients (129 eyes) attending a diabetic eye clinic, were tested. The test correctly identified 91% of eyes with good macular function and 77% of eyes with poor macular function (visual acuity 6/24 or poorer). If a vascular pattern was seen, it was probable (0.89) that good macular function was present. If no vascular pattern was seen, it was probable (0.80) that the eye had poor macular function (chi 2 = 60.14, P = < 0.001). Our results were superior to those previously reported. We attribute the increased accuracy of our test to the brighter light source used.

Adult↗
PubMed2003

Electrophysiology and ocular blood flow in a family with dominant optic nerve atrophy and a mutation in the OPA1 gene.

OBJECTIVE: To characterize the clinical phenotype, with emphasis on electrophysiology and blood flow measurements, of a family with dominant optic nerve atrophy and an identified mutation in the OPA1 gene. METHODS: Seven family members were examined. Ophthalmological evaluation included testing of visual acuity, ophthalmolscopy, kinetic perimetry, color vision testing, full-field electroretinography (ERG), multifocal electroretinography (MERG), and multifocal visual evoked potential (MVEP). Retrobulbar arterial blood flow and retinal capillary perfusion was measured in three patients using scanning laser Doppler flowmetry (SLDF) and color Doppler imaging techniques. PCR-SSCP and DNA sequencing determined the presence of a mutation in exon 18 of the OPA1 gene. RESULTS: The clinical characteristics varied considerably in the family. The ERG and the MERG demonstrated normal retinal function, while the MVEP was abnormal in all examined patients. Retinal and optic nerve head capillary perfusion was significantly decreased in the three patients examined with SLDF. Retrobulbar blood flow velocities were significantly decreased in the central retinal and ophthalmic arteries. In all seven examined subjects, a microdeletion (1756-1767del(12 bp)) in the OPA1 gene was identified. CONCLUSION: Patients with a mutation in the OPA1 gene have a very variable phenotype. MVEP and blood flow measurements are two new objective methods for an easier detection of this specific genetic optic nerve atrophy.

Adolescent↗